228 related articles for article (PubMed ID: 12560674)
1. Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels.
Bayat A; Bock O; Mrowietz U; Ollier WE; Ferguson MW
Plast Reconstr Surg; 2003 Feb; 111(2):535-43; discussion 544-6. PubMed ID: 12560674
[TBL] [Abstract][Full Text] [Related]
2. Genetic susceptibility to keloid disease and transforming growth factor beta 2 polymorphisms.
Bayat A; Bock O; Mrowietz U; Ollier WE; Ferguson MW
Br J Plast Surg; 2002 Jun; 55(4):283-6. PubMed ID: 12160532
[TBL] [Abstract][Full Text] [Related]
3. Genetic susceptibility to keloid disease: transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease.
Bayat A; Bock O; Mrowietz U; Ollier WE; Ferguson MW
Exp Dermatol; 2004 Feb; 13(2):120-4. PubMed ID: 15009106
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of p53 polymorphism for genetic predisposition of keloid and hypertrophic scar].
Wang CM; Hiko H; Nakazawa N
Zhonghua Zheng Xing Wai Ke Za Zhi; 2005 Jan; 21(1):32-5. PubMed ID: 15844595
[TBL] [Abstract][Full Text] [Related]
5. Genetic susceptibility in Dupuytren's disease. TGF-beta1 polymorphisms and Dupuytren's disease.
Bayat A; Watson JS; Stanley JK; Alansari A; Shah M; Ferguson MW; Ollier WE
J Bone Joint Surg Br; 2002 Mar; 84(2):211-5. PubMed ID: 11924651
[TBL] [Abstract][Full Text] [Related]
6. [Changes in TGF-beta 1 and type I, III procollagen gene expression in keloid and hypertrophic scar].
Tang S; Pang S; Cao Y
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1999 Jul; 15(4):283-5. PubMed ID: 11593607
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection.
Wang H; Mengsteab S; Tag CG; Gao CF; Hellerbrand C; Lammert F; Gressner AM; Weiskirchen R
World J Gastroenterol; 2005 Apr; 11(13):1929-36. PubMed ID: 15800982
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation.
Colwell AS; Phan TT; Kong W; Longaker MT; Lorenz PH
Plast Reconstr Surg; 2005 Oct; 116(5):1387-90; discussion 1391-2. PubMed ID: 16217483
[TBL] [Abstract][Full Text] [Related]
9. Influence of Transforming Growth Factors beta 1 and beta 3 in the Scar Formation Process.
Lee JS; Cho HG; Lee JW; Oh EJ; Kim HM; Ko UH; Kang M; Shin JH; Chung HY
J Craniofac Surg; 2023 May; 34(3):904-909. PubMed ID: 36730874
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo.
Tredget EE; Wang R; Shen Q; Scott PG; Ghahary A
J Interferon Cytokine Res; 2000 Feb; 20(2):143-51. PubMed ID: 10714549
[TBL] [Abstract][Full Text] [Related]
11. Genetic susceptibility to dupuytren disease: association of Zf9 transcription factor gene.
Bayat A; Watson JS; Stanley JK; Ferguson MW; Ollier WE
Plast Reconstr Surg; 2003 Jun; 111(7):2133-9. PubMed ID: 12794452
[TBL] [Abstract][Full Text] [Related]
12. The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation.
Lu L; Saulis AS; Liu WR; Roy NK; Chao JD; Ledbetter S; Mustoe TA
J Am Coll Surg; 2005 Sep; 201(3):391-7. PubMed ID: 16125072
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b.
Tredget EE; Shankowsky HA; Pannu R; Nedelec B; Iwashina T; Ghahary A; Taerum TV; Scott PG
Plast Reconstr Surg; 1998 Oct; 102(5):1317-28; discussion 1329-30. PubMed ID: 9773986
[TBL] [Abstract][Full Text] [Related]
14. Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar.
Sideek MA; Teia A; Kopecki Z; Cowin AJ; Gibson MA
J Mol Histol; 2016 Feb; 47(1):35-45. PubMed ID: 26644005
[TBL] [Abstract][Full Text] [Related]
15. [Analysis on polymorphism at -509 C/T site of TGF-β1 gene in patients with keloids].
Song M; Liu Y
Zhonghua Shao Shang Za Zhi; 2014 Dec; 30(6):482-6. PubMed ID: 25608783
[TBL] [Abstract][Full Text] [Related]
16. Adipose tissue-derived stromal cells inhibit TGF-β1-induced differentiation of human dermal fibroblasts and keloid scar-derived fibroblasts in a paracrine fashion.
Spiekman M; Przybyt E; Plantinga JA; Gibbs S; van der Lei B; Harmsen MC
Plast Reconstr Surg; 2014 Oct; 134(4):699-712. PubMed ID: 25357030
[TBL] [Abstract][Full Text] [Related]
17. Association of TGFβ1 and clinical factors with scar outcome following melanoma excision.
Ward SV; Cadby G; Heyworth JS; Fear MW; Wallace HJ; Cole JM; Wood FM; Palmer LJ
Arch Dermatol Res; 2012 Jul; 304(5):343-51. PubMed ID: 22566144
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1-antisense modulates the expression of hepatocyte growth factor/scatter factor in keloid fibroblast cell culture.
Naim R; Naumann A; Barnes J; Sauter A; Hormann K; Merkel D; Aust W; Braun T; Bloching M
Aesthetic Plast Surg; 2008 Mar; 32(2):346-52. PubMed ID: 18087663
[TBL] [Abstract][Full Text] [Related]
19. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells.
Wang R; Ghahary A; Shen Q; Scott PG; Roy K; Tredget EE
Wound Repair Regen; 2000; 8(2):128-37. PubMed ID: 10810039
[TBL] [Abstract][Full Text] [Related]
20. Prospective analysis of single nucleotide polymorphisms of the transforming growth factor beta-1 gene in Peyronie's disease.
Hauck EW; Hauptmann A; Schmelz HU; Bein G; Weidner W; Hackstein H
J Urol; 2003 Jan; 169(1):369-72. PubMed ID: 12478192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
